Metabolic liver health · WEST DELHI

Fatty liver: is there scarring?

An ultrasound can show liver fat. It cannot, by itself, tell you the cause, the degree of inflammation or your long-term fibrosis risk.

30+ yearsSpecialist perspectiveMedical + proceduralOne connected pathwayTwo clinicsMoti Nagar · Paschim Vihar
Liver and biliary anatomy with responsive labels for metabolic risk, inflammation and fibrosisMASLD-01
METABOLIC LIVER RISKFat is only the first question.

Metabolic risk · inflammation · fibrosis · trend · action

Conceptual educational visualisation — not diagnostic imagery

01 / BEGIN WITH THE PATTERN

Does this sound familiar?

Fatty liver on ultrasound, metabolic risk or concern about inflammation and scarring

01

MASLD describes fatty liver associated with cardiometabolic risk. Many people have no obvious symptoms. The key clinical question is not simply whether fat is present, but whether there is inflammation, scarring or a risk of progression.

START HERE

You do not need to identify the diagnosis yourself. Bring the pattern, previous treatment and what still feels unexplained.

02 / BEYOND THE ULTRASOUND LABEL

PATTERN · TREND · RISK

Fat in the liver is a finding. The clinical question is what risk sits behind it.

Blood-test patterns, metabolic context, fibrosis assessment and change over time are interpreted together.

An editorial medical illustration of the liver, gallbladder, bile ducts, pancreatic head and duodenumVIS / EVIDENCE / 10
READ THE PATTERNA result is a clue. The pattern and trend provide context.

Results are interpreted alongside symptoms, medicines, metabolic risk and imaging.

AI-assisted editorial visual using abstract, de-identified documents
03 / WHAT MATTERS NOW

Understand what changes treatment, monitoring or the need for further investigation.

Cause, severity, warning signs and the value of further investigation must be considered together.

01

Liver risk and metabolic health need to be read together

Liver health is considered alongside weight, waist measurement, glucose or diabetes, blood pressure, lipids, sleep, alcohol exposure and medicines. Non-invasive scores and elastography can help estimate fibrosis risk.

  • Liver-test pattern and platelet count
  • Diabetes and insulin resistance
  • Blood pressure and lipids
  • Alcohol and medicine review
  • Ultrasound or elastography when appropriate
02

The plan must be sustainable—and matched to risk

Nutrition, activity, metabolic risk treatment and weight management may all contribute. Medicines are selected for a person—not for a search keyword—and require discussion of benefits, side effects and contraindications.

Dr Monika Jain in her clinical coatDr Monika Jain

EXPERIENCE WITH RANGE

Experience connects the symptom, the evidence and the next clinical decision.

Dr Monika Jain brings more than three decades across medical gastroenterology, hepatology, diagnostic and therapeutic endoscopy, clinical leadership and specialist teaching. For metabolic liver health, that range helps keep investigation and treatment connected to a defined purpose.

30+ yearsSpecialist practiceDirector since 2014Gastroenterology & HepatologyMedical + proceduralOne connected perspective
Meet Dr Jain and review her professional journey ↗
FREQUENTLY ASKED

Questions patients ask before the next step.

Clear general guidance, with the limits made visible.

01Does fatty liver always mean permanent liver damage?

No. Fat on imaging does not by itself establish inflammation, fibrosis or cirrhosis. Risk assessment combines metabolic history, blood tests, platelets, imaging and sometimes elastography.

02Can liver disease be present without symptoms?

Yes. Metabolic liver disease and fibrosis may remain quiet, which is why risk and trends matter even when a person feels well.

03What does FibroScan add to an ultrasound?

Ultrasound can identify fatty change; elastography estimates liver stiffness and can help assess fibrosis risk. Neither result should be interpreted in isolation.

04Are weight-loss medicines a treatment for fatty liver?

Metabolic improvement may support liver health, but medicine selection depends on the individual, indication, expected benefit, side effects and contraindications.

05Which reports should I bring?

Bring liver-test trends, platelet count, glucose or HbA1c, lipid results, ultrasound or FibroScan reports and a full medicine and alcohol history.

06Where can I request a liver consultation?

Dr Jain’s clinic team can receive requests for Moti Nagar or Paschim Vihar and confirm the appropriate consultation time.

MOTI NAGAR · PASCHIM VIHAR

Consult Dr Monika Jain in West Delhi.

Choose the more convenient location for Metabolic liver health, review the real address and let the clinic team confirm Dr Jain’s availability before you travel.

THE NEXT LOGICAL QUESTION

Follow the decision—not a disconnected list of pages.

Fatty liver on ultrasound, metabolic risk or concern about inflammation and scarring

EDITORIAL RECORDPublished and updated 28 July 2026Prepared by the Dr Monika Jain Editorial Team · Medical reviewer is named only after approval
Medical sources used for this page

These sources support the general educational information. They do not replace individual interpretation.

AASLD — MASLD assessment and management↗NIDDK — Fatty liver disease↗